v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,593.1 $ 1,697.2
Marketable investments 1,455.6 1,569.8
Accounts receivable, no allowance for 2025 and 2024 379.3 279.3
Inventories, net 169.2 157.9
Other current assets 229.7 169.7
Total current assets 3,826.9 3,873.9
Marketable investments 1,917.7 1,475.3
Goodwill and other intangible assets, net 111.5 111.9
Property, plant, and equipment, net 1,362.4 1,222.4
Deferred tax assets, net 456.2 458.4
Other non-current assets 233.3 222.1
Total assets 7,908.0 7,364.0
Current liabilities:    
Accounts payable and accrued expenses 432.0 344.5
Line of credit 0.0 300.0
Other current liabilities 95.1 93.6
Total current liabilities 527.1 738.1
Other non-current liabilities 207.3 181.9
Total liabilities 734.4 920.0
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, par value $.01, 10,000,000 shares authorized, no shares issued 0.0 0.0
Common stock, par value $.01, 245,000,000 shares authorized, 75,381,852 and 74,997,896 shares issued, and 45,215,262 and 44,831,306 shares outstanding as of June 30, 2025 and December 31, 2024, respectively 0.8 0.8
Additional paid-in capital 2,793.4 2,698.9
Accumulated other comprehensive loss 0.0 (3.4)
Treasury stock, 30,166,590 shares as of June 30, 2025 and December 31, 2024, respectively (3,474.5) (3,474.5)
Retained earnings 7,853.9 7,222.2
Total stockholders’ equity 7,173.6 6,444.0
Total liabilities and stockholders’ equity $ 7,908.0 $ 7,364.0